AbbVie Inc. Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AbbVie Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AbbVie Inc. for February 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21 2017 | ABBV | AbbVie Inc. | AbbVie Inc. | 10% Owner | Option Exercise | C | 0.00 | 1,505,241 | 0 | 0 | |
| Feb 21 2017 | ABBV | AbbVie Inc. | AbbVie Inc. | 10% Owner | Buy | C | 0.00 | 1,505,241 | 0 | 1,640,473 | 135.2 K to 1.6 M (+1,113.08 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Option Exercise | A | 61.36 | 100,100 | 6,142,136 | 100,100 | |
| Feb 21 2017 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Grant | A | 0.00 | 15,375 | 0 | 192,830 | 177.5 K to 192.8 K (+8.66 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Grant | A | 0.00 | 34,173 | 0 | 177,455 | 143.3 K to 177.5 K (+23.85 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Option Exercise | A | 61.36 | 78,340 | 4,806,942 | 78,340 | |
| Feb 21 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Grant | A | 0.00 | 14,035 | 0 | 122,410 | 108.4 K to 122.4 K (+12.95 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Grant | A | 0.00 | 31,196 | 0 | 108,375 | 77.2 K to 108.4 K (+40.42 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | A | 61.36 | 100,100 | 6,142,136 | 100,100 | |
| Feb 21 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 15,945 | 0 | 223,755 | 207.8 K to 223.8 K (+7.67 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 35,440 | 0 | 207,810 | 172.4 K to 207.8 K (+20.56 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | A | 61.36 | 95,750 | 5,875,220 | 95,750 | |
| Feb 21 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 13,350 | 0 | 192,466 | 179.1 K to 192.5 K (+7.45 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 29,672 | 0 | 179,116 | 149.4 K to 179.1 K (+19.85 %) |
| Feb 03 2017 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | M | 27.29 | 2,400 | 65,496 | 0 | |
| Feb 03 2017 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Payment of Exercise | F | 60.89 | 1,558 | 94,867 | 3,873 | 5.4 K to 3.9 K (-28.69 %) |
| Feb 03 2017 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Buy | M | 27.29 | 2,400 | 65,496 | 5,431 | 3 K to 5.4 K (+79.18 %) |